BRANFORD, Conn., Feb. 2, 2018 /PRNewswire-PRWeb/ -- ABCT, Connecticut's newest life
The selected startups were chosen through an extensive screening process, which includes experts who rated ventures based on metrics including the strength of the team, uniqueness of insights into the problems they are solving, and their capacity to revolutionize the life science industry.
ABCT 2018 Cohort Ventures:
About ABCT ABCT is a competitive entry, 6-month long program that helps emerging bioscience ventures grow by providing entrepreneurship education and business networking to access global funders and prospective team members. ABCT aims to support the development of Connecticut as a hub of bioscience invention and commercialization by harnessing the creativity and ambition present in the state's academic institutions, spinouts from established institutions and serial entrepreneurs and connect this talent with the scientific experts and business leaders in CT, NYC, and globally. ABCT supports young entrepreneurs by providing them with the education and networks critical to start successful bioscience based businesses. Local and global corporations are supporting the ABCT program including Purdue Pharma, Pfizer, Microsoft, Kaneka and Shipman and Goodwin. For more information see ABCT.com
About Design Technologies Design Technologies helps build emergent IP focused ventures and founded ELabNYC, the successful biosciences pre-accelerator program in NYC for research institution spin outs. ELabNYC is currently working with its 6th program cohort. ELabNYC's 95 alumni ventures raised $45M during the program and $190M subsequent to graduation, including Landos - $10M closed with Perceptive/Xontogeny in September 2017.
SOURCE Accelerator for Biosciences in Connecticut
Subscribe to our Free Newsletters!
Some drugs or therapeutic agents cause undesirable reactions in lungs, known as drug-induced ...
Sleep disorders are collectively known as ''Somnipathy.'' There are over 70 different medically ...View All